MEROPENEM JUNO (Juno Pharmaceuticals Pty Ltd)
Product name
MEROPENEM JUNO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 working days (255)
Active ingredients
meropenem trihydrate
Registration type
New generic medicine
Indication
MEROPENEM JUNO (powder for injection) is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:
- Community acquired lower respiratory tract infection
- Hospital acquired lower respiratory tract infection
- Complicated urinary tract infectionFebrile neutropaenia
- Intra-abdominal and gynaecological (poly microbial) infections
- Complicated skin and skin structure infections
- Meningitis
- Septicaemia